Von Willebrand syndrome treatment

Von Willebrand syndrome (VWS) is a complex hemostasis disorder. It is the most common congenital bleeding disorder and is caused by deficiencies or qualitative defects in von Willebrand factor (VWF), a high molecular weight adhesive protein. In addition, acquired VWS can occur as a result of various underlying diseases.

The severity of the bleeding tendency differs considerably depending on the type and subtype of VWS. Therefore, in addition to the basic diagnosis of VWS, it is always necessary to determine the type and subtype. In many cases, this requires highly specialized diagnostics, which is guaranteed in Switzerland by the cooperation of several university centers

The hemostasis laboratory at the Department of Hematology offers comprehensive diagnostics for suspected VWS:

  • Antigen concentration and functional activity of the VWF
  • Factor VIII activity
  • Ristocetin-induced platelet agglutination
  • VWF propeptide (turnover marker)
  • Factor VIII binding capacity of the VWF
  • After shipment to other centers: multimeric analysis, collagen binding activity of the VWF

Responsible professionals

Jan-Dirk Studt, PD Dr. med.

Senior Physician, Department of Medical Oncology and Hematology

Tel. +41 44 255 37 82
Specialties: Blood clotting, Diagnostics, Academic Director - Department of Hemostasis

For patients

As a patient, you cannot register directly for a consultation. Please get a referral from your primary care physician, specialist. For questions please use our contact form.

Contact form

For referrering physicians

University Hospital Zurich
Department of Medical Oncology and Hematology
Raemistrasse 100
8091 Zurich

Tel. +41 44 255 38 99
Patient registration form